Presentation Transcript
COINCIDENCE IMAGINGWITH 18F-FDG :COINCIDENCE IMAGINGWITH 18F-FDG
Clinical Coincidence Systems :Clinical Coincidence Systems PET Scanner
Molecular Coincidence Detection Gamma Camera (MCD)
PET Scanners :PET Scanners Technically well developed
Tomographic
Quantitative
Complex to operate
Expensive
Single purpose
MCD Gamma Cameras :MCD Gamma Cameras New technology
Simple to operate
Relatively inexpensive
Tomographic
Multi-purpose
Not yet quantitative
The Tools of the Trade :The Tools of the Trade Positron radioemitters
Coincidence detection
Radiolabeled sugars
Powerful computers
Why Positrons? :Why Positrons? What is a positron?
Positrons are positively charged electrons emitted during nuclear decay
Annihilated quickly by negative electrons (negatrons)
PET Imaging :PET Imaging e+ e- 511 511 ANNIHILATION
Coincidence Detection :Coincidence Detection We only want to find events that arise from annihilation of positrons.
Since these events are 180 degrees apart, we need two opposing detectors looking at the source.
Using computers to time the arrival of photons at the source, we can determine which are coincident events.
The Power of Coincidence :The Power of Coincidence Scatter is markedly reduced
Contrast and resolution are improved
More counts for the same dose (better statistics)
Potentially quantitative
Total Coincidence Count :Total Coincidence Count Total = Trues + Randoms + Scatter Random and scatter scatter account for ~ 25% in PET scanners, and ~ 30-50% in hybrid gamma cameras.
Adds a flat background to the reconstructed images resulting in less contrast.
True Count :True Count Coincident detection of 511 KeV photons emitted from positron-electron annihilations that occurs within the sensitive volume of two opposing detectors. Trues count rate is proportional to the activity present within the sensitive volume 1 2
Random Count :1 2 Random Count Randoms = (Det 1 Singles) * (Det 2 Singles) *
(Coincidence Timing Window) Coincident detection of un-correlated 511 KeV photons from positron-electron annihilations, leading to erroneous recording of projection ray. * *
Scatter Count :Scatter Count Coincident detection of 511 keV photons from a positron-electron annihilation, but one has scattered leading to erroneous recording of projection ray. * *
CORRECT PEAKING :CORRECT PEAKING
ATTENUATION CORRECTION :ATTENUATION CORRECTION The 137Cs attenuation correction source and 18F emission source energy peaks should be checked prior to each study with patient on the table
The 137Cs sources must be removed prior to acquiring a study in normal mode. Otherwise, these sources will produce 100 cts/sec in normal imaging mode
ATTENUATION CORRECTION :ATTENUATION CORRECTION Attenuation correction creates a tissue density map to compensate for non-uniform densities in patient
It compensates for varying body thickness, which will cause decreased activity in the midline of the patient
Without transmission imaging, the FDG uptake in the lungs is artifactually high
FDG Attenuation Correction :FDG Attenuation Correction Important step to quantification
Improves cardiac studies
Improves visualization of deep structures
Mediastinum
Abdomen
Photon Attenuation Single Photon vs. Coincidence :Photon Attenuation Single Photon vs. Coincidence Attenuation higher—Coincidence path length is longer Coincidence Collimated Detector 1 Detector 2
Factors Affecting Attenuation Corrected Image Quality :Factors Affecting Attenuation Corrected Image Quality Large Patients
Attenuation of deep structures
Mediastinum
Liver
Abdomen
Reconstruction Method
Iterative vs. Filtered Back Projection
Scatter and Random Corrections
Attenuation Correction(Reconstruction Methods) :Attenuation Correction(Reconstruction Methods) Filtered
Back
Projection
Iterative
Transmission Acquisition :Transmission Acquisition Transmission Acquisition
TX source translates
Collimated fan beam
Slit 13 cm by 58 cm
Scanning window synchronized with source
360° continuous rotation
Table movement
Attenuation Correction :Attenuation Correction Separate attenuation map created
One rotation around patient (4-6 minutes) for each bed position
Data sampling every 3.9 degrees
Iterative reconstruction
Reconstruct with or without AC using the same dataset
Slide 28:Transmission Projection Images Loyola University Medical Center Images adjusted for photography Reconstructed Attenuation Maps
Slide 29:Attenuation Correction Loyola University Medical Center No Attenuation Correction
Slide 30:Attenuation Correction No Attenuation Correction Loyola University Medical Center
Slide 31:Attenuation Correction No Attenuation Correction Loyola University Medical Center
Attenuation Correction/ No correction :Attenuation Correction/ No correction
Slide 33:Corrected Non corrected Loyola University Medical Center
Artifacts :Artifacts In 3/44 cases, artifacts such as streaking were seen on corrected scans
In 20/44, cases artifacts were seen on the uncorrected scans that were not seen on corrected studies
In 3/44 cases, artifacts were seen on both corrected and uncorrected data. When artifacts were seen on corrected studies, they were also seen on uncorrected studies.
Lesion Identification :Lesion Identification In 18/44 patients, lesions were seen on the corrected scan that were not seen (or were poorly seen) on the uncorrected studies.
In 3/44 patients, lesions were seen on the uncorrected studies that were not seen on the corrected studies.
Recommend reviewing both uncorrected and corrected images.
ADVANTAGES OF FDG :ADVANTAGES OF FDG Capability to detect unsuspected mets distant from original location
With fusion of MRI & CT/FDG studies, greater accuracy can be accomplished in preliminary diagnosis = cost effective management of disease
Radiolabeled Sugars :Radiolabeled Sugars There is increased sugar utilization in many tumors
An inability to metabolize deoxyglucose retains FDG longer than normal sugars
Lung cancer, breast cancer, melanoma, and colon cancer all show increased sugar uptake
How to label a sugar without changing its properties?
Radiolabeled Sugars :Radiolabeled Sugars The best label to date is fluorine-18
The compound of choice is fluorodeoxyglucose
FDG behaves like glucose
Has a tightly bound radionuclide
Rapid tumor uptake
WHY DO PHYSICIANSORDER FDG STUDIES? :WHY DO PHYSICIANSORDER FDG STUDIES? Evaluation of pulmonary nodules
Detecting, monitoring, and staging of cancer
Post-therapy evaluation of disease
GLUCOSE PARAMETERS :GLUCOSE PARAMETERS Have patients refrain from any sugar intake post injection
Allow adequate time to adjust glucose levels in cardiac patients using insulin or glucose, as appropriate. Ideal range: 90-130 mg/dl
Diabetics are allowed to have a light meal up to four hours before their appointed time
PATIENT POSITIONING :PATIENT POSITIONING Perfect centering of target organ is critical for counting efficiency
Pillows and other positioning devices may be used to immobilize patient and to maintain patient comfort
Patient motion is prohibited during the emission and transmission studies to prevent imaging artifacts
QUALITY CONTROL :QUALITY CONTROL Adequate time must be allowed to perform quality control testing to ensure consistency. Includes
Tc-99m flood, emission and transmission floods
Flood data from both the emission and Attenuation Correction sources should be analyzed
ACQUISITION PROTOCOL :ACQUISITION PROTOCOL STUDY TIME/STEP FOV
Brain 80 sec/azimuth 38 cm2 /center
Cardiac 60 sec/azimuth 38 cm2/center
Whole Body 40 sec/azimuth Full Field
Slide 44:RAW DATA TRANSMISSION
PROCESSED CORONAL SLICES :PROCESSED CORONAL SLICES
PROCESSED SAGITAL SLICES :PROCESSED SAGITAL SLICES
PROCESSED TRANSVERSE SLICES :PROCESSED TRANSVERSE SLICES
KNIT DATA :KNIT DATA
Clinical Cases :Clinical Cases Normal case
Cardiac uptake
Minimal diffuse abdominal uptake
Clinical Cases :Clinical Cases 50-year-old female with left rib pain
X-rays negative
Bone scan shows spine lesions
Breast biopsy shows cancer
Are there other lesions?
Clinical Cases :Clinical Cases 80 year-old-male with relapsed non Hodgkin's lymphoma
CT shows an abnormal kidney and one enlarged left inguinal node
FDG shows more extensive disease
Clinical Cases :Clinical Cases 62-year-old female with squamous cell tumor of the head and neck
Completed course of radiotherapy
MCD study done to check for residual disease
Uptake seen in the lung
Clinical Cases :Clinical Cases 36-year-old female post-op colon cancer
CEA rising
CT shows possible pelvic mass
FDG performed to assess the likelihood of tumor
Clinical Cases :Clinical Cases 47-year-old female with recurrent colon cancer
CT shows a mass in the head of the pancreas and no other definite disease
MCD study performed to see if curative surgery was possible
Clinical Cases :Clinical Cases 56-year-old male with pulmonary metastasis from colon cancer
Being considered for curative resection
CT of abdomen shows post surgical changes and questionable nodes
Slide 68:Artifact/ Injected in the Light
Slide 69:ARTIFACT/MUSCLE UPTAKE
ARTIFACT/ INJECTION SITE :ARTIFACT/ INJECTION SITE
ARTIFACT/ HIGH COUNT RATE :ARTIFACT/ HIGH COUNT RATE
Clinical Case :Clinical Case 50-year-old female with left rib pain
X-rays negative
Bone scan shows spine lesions
Breast biopsy shows cancer
Can we follow disease with FDG?
Slide 74:Corrected Uncorrected
Slide 75:Corrected Uncorrected
Clinical Cases :Clinical Cases One year post therapy with Tamoxifen
Radiation therapy to T-12 to L-2
Treated with bisphosphonate
Repeat bone scan and FDG
Clinic Cases :Clinic Cases 18 months post diagnosis
Bone scan shows new neck lesion
No change in thoracic and lumbar lesions on bone scan
FDG shows tumor recurrence at previously radiated site
Therapy changed
Slide 81:Pre RX Post RX 18 months later
Clinical Cases :Clinical Cases 29 year-old female with an axillary mass
Biopsy compatible with breast cancer
Mammogram negative
Ultrasound negative
Slide 83:Corrected Uncorrected Corrected
Cardiac Applications :Cardiac Applications Detects viable, but hypoperfused myocardium
Hibernating myocardium
Blood sugar must be between 90 and 130 mg%
May require sugar or insulin to adjust
Slide 87:Attenuation Correction No Attenuation Correction Attenuation Correction No Attenuation Correction
Radiation Dosimetry to Patient :Radiation Dosimetry to Patient FDG is ultra-short half-life
Whole body and bladder dose similar to bone scan
About 2 to 3 rads whole body
Conclusions :Conclusions FDG gamma camera coincidence imaging is feasible in a routine nuclear medicine lab
Gamma camera FDG studies provide additional diagnostic information
Attenuation correction improves both visual and diagnostic quality of FDG images
MCD Future :MCD Future Validate utility in various disease states
Demonstrate cost/benefit
Continue to develop clinical protocols
Increasing number of units in the U.S.
In 1995, there were 60 PET units today over 500 coincidence devices
Increased Integration with CT and MRI